Thromboembolism Prophylaxis clinical trials

Explore recruiting thromboembolism prophylaxis clinical trials.

Recruiting thromboembolism prophylaxis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Thromboembolism Prophylaxis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Comparison of the effects of prophylactic administration of Apixaban on thrombin generation in patients with de novo multiple myeloma and patients undergoing a surgery for total knee replacement: the ProApix Study

France

Therapeutic use (Phase IV) EU CTIS Study details

Cluster randomised trial of low molecular weight heparins - Directly through Epic

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

(19767 OCEANIC-AF) A multicenter, international, randomized, active comparator-controlled, double-blind, double-dummy, parallel-group, 2-arm, Phase 3 study to compare the efficacy and safety of the oral FXIa inhibitor asundexian (BAY 2433334) with apixaban for the prevention of stroke or systemic embolism in male and female participants aged 18 years and older with atrial fibrillation at risk for stroke

Finland, Norway, Denmark, Hungary, Spain, Estonia +16 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Thromboembolism Prophylaxis trials by city

Thromboembolism Prophylaxis in Toronto Thromboembolism Prophylaxis in Vancouver Thromboembolism Prophylaxis in Montreal Thromboembolism Prophylaxis in Calgary Thromboembolism Prophylaxis in Edmonton Thromboembolism Prophylaxis in Ottawa Thromboembolism Prophylaxis in Winnipeg Thromboembolism Prophylaxis in Quebec City Thromboembolism Prophylaxis in Hamilton Thromboembolism Prophylaxis in Kitchener Thromboembolism Prophylaxis in London Thromboembolism Prophylaxis in Halifax Thromboembolism Prophylaxis in New York Thromboembolism Prophylaxis in Los Angeles Thromboembolism Prophylaxis in Chicago Thromboembolism Prophylaxis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease